Medical Weight Loss for Portsmouth, New Hampshire Residents

Portsmouth, New Hampshire residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Portsmouth through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Flexible payment for Portsmouth residents: we accept HSA, FSA, Klarna, and Affirm, so paying for your New Hampshire telehealth program can fit your budget. Medication is billed separately. Doctor review just $119 (medication separate).

Why Portsmouth Residents Choose New Hope Weight Loss

You never have to leave Portsmouth to work with us. The entire program runs by telehealth from our clinic in Costa Mesa, California, so your consultation, your follow-ups, and your dose adjustments all happen by video and message from wherever you are in New Hampshire. Whether you live near historic downtown Portsmouth and the Seacoast region of Rockingham County or further out, the care is identical. No commute, no waiting room, no rearranging your week around an appointment across town.

Portsmouth is part of the area New Hope Weight Loss serves by telehealth. The same compounded semaglutide and tirzepatide protocols, the same flat pricing, and the same bilingual support reach Portsmouth patients at home.

Telehealth is what lets us care for Portsmouth, New Hampshire from a single office in Costa Mesa, so you get Dr. Sharma's full attention without rearranging your day around an appointment across town. We care for patients throughout historic downtown Portsmouth and the Seacoast region of Rockingham County. You can have your first video visit from your kitchen in Portsmouth and have your treatment plan in motion the same week.

Distance simply stops mattering here, since every appointment for Portsmouth residents takes place over secure video rather than in a waiting room. Because every Portsmouth visit happens by video, there is no local office to drive to and no travel cost added to your $119 review. New Hope Weight Loss reaches patients all across New Hampshire by secure telehealth from our Costa Mesa, California clinic, delivering physician-supervised care without any travel.

GLP-1 Weight Loss Programs Available

Which GLP-1 program is right for you?

Our 90-Day Metabolic Reset runs on semaglutide, the same active ingredient as Wegovy and Ozempic. It starts at $166 a month, or $499 for 90 days, and branded-drug trials reported average loss near 15 to 17 percent. Because compounded semaglutide is not FDA-approved or brand-identical, results vary. Dr. Sharma guides every Portsmouth patient by telehealth.

And if you want more horsepower

Tirzepatide, from $233 a month, adds GIP to the usual GLP-1 action. In branded-drug trials, dose-qualified participants reached up to 22.5 percent loss, which is not the typical outcome. It shares its active ingredient with Mounjaro and Zepbound.

A $119 physician review starts the process. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Portsmouth

The path from curious to treated is short, and it all runs through your screen. People in Portsmouth start by completing a health-and-weight intake quiz online. Dr. Anjmun Sharma reviews every answer and meets you over secure video, usually within 48 hours, to talk through whether a compounded GLP-1 like semaglutide or tirzepatide fits your goals and history. When she prescribes, a state-licensed 503(a) pharmacy ships the medication to your Portsmouth home in cold-pack packaging designed to keep it stable. After that, you and Dr. Sharma stay connected through video follow-ups, so your progress is supported from any corner of .

Frequently Asked Questions, Portsmouth

Where is the New Hope Weight Loss location serving Portsmouth?

The location serving Portsmouth is our Costa Mesa, California clinic, which is our only physical site. We care for Portsmouth, New Hampshire patients through telehealth rather than a local office. Dr. Anjmun Sharma confirms your eligibility for a compounded GLP-1 plan during a private video consult.

Is remote care a real option for Portsmouth patients?

It is the standard for Portsmouth. The whole program runs on telehealth, so consults, follow-ups, and support happen wherever you are. When Dr. Sharma approves you, compounded medication ships to Portsmouth in cold-pack packaging engineered to keep it at a safe temperature in transit.

How much does a Portsmouth patient pay overall?

The physician review is $119. Compounded semaglutide is offered from $166 monthly, or $499 for 90 days, and tirzepatide from $233 monthly. The medication is billed separately from the visit. We accept HSA, FSA, Klarna, and Affirm, and we apply no distance surcharge for Portsmouth patients.

What areas of Portsmouth do you serve?

We serve patients from across Portsmouth by telehealth, including historic downtown Portsmouth and the Seacoast region of Rockingham County.

Is bilingual (Spanish) telehealth care available for Portsmouth patients?

Yes. Anamaria Schmidt, our bilingual clinical coordinator, handles calls, WhatsApp, and Spanish-language consultations, with Dr. Sharma supervising every case. The full telehealth program, intake, consultation, and follow-up, is available in Spanish for Portsmouth patients.

Portsmouth Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Portsmouth, New Hampshire by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.